Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trialsHiddo J.L. Heerspink, Ron T. Gansevoort, Josef Coresh et al.|The Lancet Diabetes & Endocrinology|2019Cited by 372
GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Meta-Analysis of Treatment Effects of Randomized Controlled TrialsLesley A. Inker, Tom Greene, Hiddo J.L. Heerspink et al.|Journal of the American Society of Nephrology|2019Cited by 295